Prevalence and risk factors of non-insulin-dependent diabetes mellitus in the rural and urban population of Tunisia;Diabète non insulino-dépendant: Prévalence et facteurs de risque en Tunisie

Revue d'Epidemiologie et de Sante Publique

Volumn 50, Issue 4, 2002, Pages 349-355

  Gharbi, M ^a   Akrout, M ^a   Zouari, B ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Diabetes; Epidemiology; Hyperension; Hyperlipidemia; Obesity

Indexed keywords

GLUCOSE; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR; RURAL POPULATION; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; TUNISIA; URBAN POPULATION;

ADULT; AGE FACTORS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; RURAL POPULATION; SEX FACTORS; TRIGLYCERIDES; TUNISIA; URBAN POPULATION;

EID: 0036743260     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Eschwège E, Simon D, Balkau B. Le diabète du type 2 vu par 1'épidémiologiste. Manage Health Outcome 1998; 4 (suppl): 1-12.
2. King H, Rewers M. Le diabète de l'adulte: désormais un problème dans le tiers monde. Bull OMS 1992; 70: 11-6.
3. Mann JI, Houston AC. Etiology of non insulin-dependent diabetes. In: Mann JI, Pyorala K, Teuscher A, eds. Diabetes in epidemiological perspective. Edinburgh: Churchill Livingstone, 1983; 12256.
4. Papoz L, Eschwège E, Warnet JM, Richard JL, Claude JR. Incidence and risk factors of diabetes in the Paris prospective study (GREA). In: Eschwège E, ed. Advances in diabetes epidemiology. Amsterdam: Elsevier, 1982: 113-22.
5. Manson JE, Nathan DM, Krolewski AS, et al. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 637.
6. Report of a WHO Study Group. Diet, Nutrition, and the prevention of chronic diseases. WHO Technical Reports Series, N° 797. Geneva: World Health Organisation, 1990.
7. Martin FIR, Wyatt GB, Griew AR, Haurahelia M, Higginbotham L. Diabetes mellitus in urban and rural communities in Papua-New Guinea. Diabetologia 1980; 18: 369-74.
8. Taylor R, Bennett P, Uili R, et al. Diabetes in Wallis Polynesians: a comparison of residents of Wallis Island and first generation migrants to Noumea, New Caledonia. Diabetes Res Clin Pract 1985; 1: 169-78.
9. Zimmet P, Dowse G, Serjeantson, et al. The epidemiology and natural history of NIDDM. Lessons from the South Pacific. Diabetes Metab Rev 1990; 6: 91-124.
10. Ekoe JM. Recent trends in prevalence and incidence of diabetes mellitus syndrome in the world. Diabetes Rech Clin Pract 1986; 1: 249-64.
11. Papoz L, Ben Khalifa F, Eschwège E, Ben Ayed H. Diabetes mellitus in Tunisia: description in urban and rural populations. Int J Epidemiol 1988; 17: 419-22.
12. Gharbi M, Belhani A, Aouidet A, et al. Niveau des facteurs de risque cardio-vasculaire dans la population urbaine et rurale du Cap-Bon, Tunisie. Rev Epidémiol Santé Publique 1996; 44: 125-32.
13. Institut National de la Statistique, République Tunisienne. Recensement général de la population et des logements. Tunis. Imprimerie de l'Institut National de la Statistique, 1984.
14. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of separative centrifuge. Clin Chem 1972; 18: 599-605.
15. The Expert Comitee on the diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
16. Charles MA, Simon D, Balkau B, Eschwège E. Révision des critères diagnostiques du diabète. Les raisons et les conséquences. Diab Metab 1998; 24: 75-9.
17. Ghannem H, Liman K, Ben Abdelaziz A, Mtiraoui A, Hadj Fredj A, Marzouki M. Facteurs de risque des maladies cardio-vasculaires dans une communité semi-urbaine du Sahel Tunisien. Rev Epidémiol Santé Publique 1992; 40: 108-12.
18. Herman W, Ali MA, Aubert RE, Engelgau MM, et al. Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 1995; 12: 1126-31.
19. Zimmet P. Challenges in diabetes epidemiology from west to the rest. Diabetes Care 1992; 15: 232-52.
20. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
21. World Health Organization. Clinical disorders arising from dietary affluence in the Eastern Mediterranean region. WHO. EMRO Publication 1989; N° 14.
22. Ministère tunisien du Plan. Projection de la population nationale 1995-2030. L'Institut National de la Statistique, 1996.
23. Ministère tunisien de la Santé. Rapport de l'enquête nationale de morbidité et de mortalité, 1996; 2: 8-20.
24. Southwell A, Eckland D. Managing the burden of type 2 diabetes: an international survey of physicians. Prat Diab Intern 1997; 14: 201-206.
25. Kannel WB, D'Agostino RB, Wilson PW, et al. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience. Am Heart J 1990; 120: 672-8.
26. Pradines S, Berthezene F. Diabète et lipides. Rev Fr Laboratoires 1992; 233: 57-60.
27. Sigal RJ, Warram JH. The interaction between obesity and diabetes. Curr Op Endocrinol Diabetes 1996; 3: 3-9.
28. Charles MA. Actualités épidémiologiques de l'obésité et du diabète de type 2 en France. Diab Metab 2000; 26: 17-20.
29. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
30. Allemen Y, Horber FF, Colomb M, et al. Insulin sensivity and body fat distributions in normotensive parents. Lancet 1993; 341: 327-31.
31. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional therapy and risk of complications in patients with type 2 diabetes mellitus (UKPDS 33). Lancet 1998; 352: 837-53.
32. The Diabetes Control and Complications TRIAL Research Group. Lifetime benefits and coasts of intensive therapy as practices in the Diabetes Control and Complications Trial. JAMA 1996; 276: 1409-15.
33. Schwartz JS, Boccuzzi SJ, Glick H, et al. Cost effectiveness of LDL-C reduction in diabetic CHD patients implications from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96 (Suppl 1): 1504-5.
34. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomised, controlled trial on the effect of improved metabolic control on complications in non-insulindependent diabetes mellitus. Ann Intern Med 1996; 124: 136-45.
35. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes (Technical review). Diabetes Care 1999; 22: 1887-989.